Reducing the Number of CTs Performed to Monitor Personalized Dosimetry During Peptide Receptor Radionuclide Therapy (PRRT)

EJNMMI Physics - Switzerland
doi 10.1186/s40658-018-0211-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Peptide Receptor Radionuclide Therapy

Best Practice and Research in Clinical Gastroenterology
Gastroenterology
2005English

Peptide Receptor Radionuclide Therapy

2007English

Three-Dimensional Radiobiological Dosimetry of Kidneys for Treatment Planning in Peptide Receptor Radionuclide Therapy

Medical Physics
MedicineNuclear MedicineRadiologyImagingBiophysics
2012English

New Developments in Peptide Receptor Radionuclide Therapy

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Reply: Peptide Receptor Radionuclide Therapy in the United States

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

Monte Carlo Simulation in Radionuclide Therapy Dosimetry

Biomedical Journal of Scientific & Technical Research
2019English

Joint Guidance on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2013English

Calculation of Absorbed Dose Due to the 90y-Dotatoc Peptide Receptor Radionuclide Therapy by McNp5/X

Nuclear Technology and Radiation Protection
RiskNuclear EnergyEngineeringReliabilitySafetyQuality
2018English

Practıcal Aspects of 68Ga-Labelled Dota-Peptides for Peptide-Receptor Radionuclide Therapy

Journal of Engineering Technology and Applied Sciences
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy